TH
BSX icon

TCTC Holdings’s Boston Scientific BSX Stock Holding History

TCTC Holdings’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52
Closed -$4.96K – 264
2025
Q4 		$4.96K Hold
52
– – ﹤0.01% 545
2025
Q3 		$5.08K Hold
52
– – ﹤0.01% 538
2025
Q2 		$5.58K Hold
52
– – ﹤0.01% 567
2025
Q1 		$5.25K Buy
+52
New +$5.24K ﹤0.01% 598
2024
Q2 		– Sell
-20
Closed -$1.37K – 546
2024
Q1 		$1.37K Buy
+20
New +$1.29K ﹤0.01% 516
2022
Q1 		– Sell
-2,700
Closed -$114K – 437
2021
Q4 		$114K Hold
2,700
– – ﹤0.01% 250
2021
Q3 		$117K Buy
+2,700
New +$119K 0.01% 235

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TCTC Holdings's BSX Position: Q1 2026 in Review

TCTC Holdings sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 52 shares — an estimated $4.96K sold.

TCTC Holdings first reported a position in BSX in Q3 2021 and held it in 7 quarters. The position peaked at $117K in Q3 2021. 1,678 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • TCTC Holdings reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • TCTC Holdings sold 52 Boston Scientific shares in Q1 2026, an estimated $4.96K.
  • TCTC Holdings first reported a position in Boston Scientific in Q3 2021 and held it in 7 quarters.
  • TCTC Holdings's Boston Scientific position peaked at $117K in Q3 2021.
  • 1,678 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.